
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Modifying CAR-T cells with anti-checkpoints in cancer immunotherapy: A focus on anti PD-1/PD-L1 antibodies
Sajad Najafi, Keywan Mortezaee
Life Sciences (2023) Vol. 338, pp. 122387-122387
Closed Access | Times Cited: 16
Sajad Najafi, Keywan Mortezaee
Life Sciences (2023) Vol. 338, pp. 122387-122387
Closed Access | Times Cited: 16
Showing 16 citing articles:
HER2+ advanced gastric cancer: Current state and opportunities (Review)
Hui-Hui Hu, Saiqi Wang, Huichen Zhao, et al.
International Journal of Oncology (2024) Vol. 64, Iss. 4
Open Access | Times Cited: 9
Hui-Hui Hu, Saiqi Wang, Huichen Zhao, et al.
International Journal of Oncology (2024) Vol. 64, Iss. 4
Open Access | Times Cited: 9
Gp350-targeted CAR-T therapy in EBV-positive Burkitt lymphoma: pre-clinical development of gp350 CAR-T
Jiajia Wang, Huiping Wang, Yangyang Ding, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Jiajia Wang, Huiping Wang, Yangyang Ding, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Development of a CD39 nanobody and its enhancement to chimeric antigen receptor T cells efficacy against ovarian cancer in preclinical studies
Yuchen Zhang, Xian-Yang Li, Qi Deng, et al.
Theranostics (2024) Vol. 14, Iss. 16, pp. 6249-6267
Open Access | Times Cited: 4
Yuchen Zhang, Xian-Yang Li, Qi Deng, et al.
Theranostics (2024) Vol. 14, Iss. 16, pp. 6249-6267
Open Access | Times Cited: 4
Blood cancer therapy with synthetic receptors and CRISPR technology
Haiying Zhang, Mingxin Zhong, Jingdong Zhang, et al.
Leukemia Research (2025) Vol. 150, pp. 107646-107646
Closed Access
Haiying Zhang, Mingxin Zhong, Jingdong Zhang, et al.
Leukemia Research (2025) Vol. 150, pp. 107646-107646
Closed Access
Chimeric Antigen Receptor Cell Therapy: Empowering Treatment Strategies for Solid Tumors
Tang‐Her Jaing, Yi-Wen Hsiao, Yi-Lun Wang
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 2, pp. 90-90
Open Access
Tang‐Her Jaing, Yi-Wen Hsiao, Yi-Lun Wang
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 2, pp. 90-90
Open Access
Challenges and opportunities in single-domain antibody-based tumor immunotherapy
Xiaozhi Xi, Guo Shu-hua, Yuchao Gu, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189284-189284
Closed Access
Xiaozhi Xi, Guo Shu-hua, Yuchao Gu, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189284-189284
Closed Access
The role of non-malignant B cells in malignant hematologic diseases
Daquan Gao
Hematology (2025) Vol. 30, Iss. 1
Open Access
Daquan Gao
Hematology (2025) Vol. 30, Iss. 1
Open Access
Ganoderma atrum polysaccharide interferes with TLR4 against PD-1 inhibitors-induced carditis via NF-κB-NLRP3 pathway driven by IRF1/VEGFA/14–3-3γ axis in Lewis lung carcinoma mice
Jiahui Wang, Xiaoyu Mu, Wensheng Wang, et al.
Journal of Functional Foods (2025) Vol. 127, pp. 106732-106732
Closed Access
Jiahui Wang, Xiaoyu Mu, Wensheng Wang, et al.
Journal of Functional Foods (2025) Vol. 127, pp. 106732-106732
Closed Access
Secretory exosomes from modified immune cells against cancer
Asrin Mafakheri, Fardin Fathi, Jamal Majidpoor, et al.
Medical Oncology (2025) Vol. 42, Iss. 5
Closed Access
Asrin Mafakheri, Fardin Fathi, Jamal Majidpoor, et al.
Medical Oncology (2025) Vol. 42, Iss. 5
Closed Access
Reprogramming the breast tumor immune microenvironment: cold-to-hot transition for enhanced immunotherapy
Saber Imani, Reyhaneh Farghadani, Ghazaal Roozitalab, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access
Saber Imani, Reyhaneh Farghadani, Ghazaal Roozitalab, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access
Glycan Structures in Osteosarcoma as Targets for Lectin-Based Chimeric Antigen Receptor Immunotherapy
Nele Prasse, Charlotte Wessolowski, Ingo Müller, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5344-5344
Open Access | Times Cited: 1
Nele Prasse, Charlotte Wessolowski, Ingo Müller, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5344-5344
Open Access | Times Cited: 1
Non-viral expression of chimeric antigen receptors with multiplex gene editing in primary T cells
Dan Cappabianca, Jingling Li, Yueting Zheng, et al.
Frontiers in Bioengineering and Biotechnology (2024) Vol. 12
Open Access
Dan Cappabianca, Jingling Li, Yueting Zheng, et al.
Frontiers in Bioengineering and Biotechnology (2024) Vol. 12
Open Access
CAR-T Therapy can be a Useful Treatment Modality for more than Just Hematologic Malignancies
Kazuhiro Ikegame
Internal Medicine (2024)
Open Access
Kazuhiro Ikegame
Internal Medicine (2024)
Open Access
The significance of chemical transfection/transduction enhancers in promoting the viral vectors-assisted gene delivery approaches: A focus on potentials for inherited retinal diseases
Sajad Najafi, Azam Rahimpour, Hamid Ahmadieh, et al.
Electronic Journal of Biotechnology (2024)
Open Access
Sajad Najafi, Azam Rahimpour, Hamid Ahmadieh, et al.
Electronic Journal of Biotechnology (2024)
Open Access
CAR-T cell therapy: breakthroughs, challenges and emerging horizons in cancer treatment
Rajeev Goel
International Journal of Research in Medical Sciences (2024) Vol. 12, Iss. 12, pp. 4829-4841
Open Access
Rajeev Goel
International Journal of Research in Medical Sciences (2024) Vol. 12, Iss. 12, pp. 4829-4841
Open Access
Physiological markers for immunotherapeutics: a review
Durlav Chowdhury, Ashmita Das, Mrityunjay Mishra, et al.
Journal of Chemotherapy (2024), pp. 1-24
Closed Access
Durlav Chowdhury, Ashmita Das, Mrityunjay Mishra, et al.
Journal of Chemotherapy (2024), pp. 1-24
Closed Access